The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1976, 116: 568-570.
Copyright © 1976 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daha, M. R.
Right arrow Articles by Austen, K. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Daha, M. R.
Right arrow Articles by Austen, K. F.

Isolation of Alternative Pathway C3 Convertase Containing Uncleaved B and Formed in the Presence of C3 Nephritic Factor (C3NeF)

Mohammed R. Daha1, Douglas T. Fearon2 and K. Frank Austen

From the Departments of Medicine, Harvard Medical School and the Robert B. Brigham Hospital, Boston, Massachusetts 02120

Abstract

The capacity of serum from patients with membranoproliferative glomerulonephritis to interact with normal human serum to inactivate C3 was ascribed to the presence of C3 nephritic factor3 (C3NeF)4 (1). The action of C3NeF was magnesium ion dependent, operative in C4 deficient serum (2), and impaired in serum selectively deficient in B and D (3) indicating that C3 cleavage occurred by the alternative pathway. Fluid phase interaction of C3, B, and D in the presence of C3NeF permits recovery of C3 convertase with an estimated sedimentation rate of 10S containing at least C3 and B (4). The present study shows that interaction of larger amounts of C3NeF with C3 and B in the absence of D allows isolation of a 10S complex containing C3 and B, an uncleaved form of B, and manifesting C3-cleaving activity.

Materials and Methods. B (5), D (6, 7), D (7), and C3 (8, 9) were purified to homogeneity and quantitated as described.

Footnotes

3 Nomenclature: In the provisional nomenclature for the alternative pathway factors: B is synonymous with C3 proactivator and glycine-rich beta glycorprotein (GBG); Dwith C3 proactivator convertase; P represents properdin. A bar over a letter indicates the activated form of a protein.

4 Abbreviations used in this paper: C3NeF, C3 nephritic factor; GVB, Veronal-buffered saline with magnesium, calcium, and gelatin; DGVB, GVB with dextrose;*, labeled.

1 Postdoctoral fellow of the Dutch Kidney Foundation.

2 Postdoctoral fellow of the Helen Hay Whitney Foundation.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Xu, M. Ma, G. C. Ippolito, H. W. Schroeder Jr., M. C. Carroll, and J. E. Volanakis
Complement activation in factor D-deficient mice
PNAS, November 20, 2001; (2001) 261428398.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Xu, M. Ma, G. C. Ippolito, H. W. Schroeder Jr., M. C. Carroll, and J. E. Volanakis
Complement activation in factor D-deficient mice
PNAS, December 4, 2001; 98(25): 14577 - 14582.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1976 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1976 by The American Association of Immunologists, Inc. All rights reserved.